Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Core Viewpoint - Pfizer is positioning itself to enter the consumer market for obesity drugs, aiming for a market impact similar to that of its erectile dysfunction drug Viagra, which was launched in 1998 [1] Group 1 - Pfizer's CEO, Albert Bourla, indicated the company's strategic focus on obesity drugs, highlighting the potential for significant market growth [1] - The company draws parallels between the anticipated success of obesity drugs and the historical performance of Viagra, suggesting a robust consumer demand [1]